BSE filing, BSE: 544482. Summary written from the filing by ALFA Finder's alert engine.
Star Imaging and Path Lab Ltd: key numbers
- Share price
- ₹74.70
- Market cap
- ₹130.1 Cr
- Revenue (annual)
- ₹88.53 Cr
- Net profit (annual)
- ₹19.28 Cr
- P/E (TTM)
- 6.8×Sector 52.0×
- Promoter holding
- 71.92%
- FII holding
- 0.06%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Star Imaging and Path Lab Ltd
All →Star Imaging and Path Lab Business Update
Star Imaging and Path Lab has been empanelled with the Municipal Corporation of Delhi to provide diagnostic services at CGHS rates.
- From
- Municipal Corporation of Delhi (MCD)
Star Imaging and Path Lab Other Announcement
Star Imaging And Path Lab Ltd has submitted its shareholding pattern for the quarter ended September 30, 2026. The filing provides details of equity shareholdings.
Star Imaging and Path Lab Annual General Meeting
Star Imaging and Path Lab Limited held its 22nd Annual General Meeting on September 29, 2026, where shareholders considered financial statements and director re-appointments.
Star Imaging and Path Lab Production Started
Star Imaging and Path Lab has commenced commercial operations of a new CT scan diagnostic facility at R G Stone Hospital in Faridabad, Haryana.
Star Imaging and Path Lab Annual General Meeting
Star Imaging and Path Lab Limited has scheduled its 22nd Annual General Meeting for September 29, 2026. The meeting will be conducted via video conferencing.
Star Imaging and Path Lab Annual Report
Star Imaging and Path Lab Limited has released its Annual Report for FY 2025-26. The 22nd AGM is scheduled for September 29, 2026, via video conferencing.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.